Introducing our groundbreaking product, the Troponin T Rapid Test Device, an integral part of our comprehensive CMC Combo Test suite. This revolutionary product utilizes innovative immunoassay technology to accurately detect the presence of cardiac troponin T (cTnT) in whole blood, serum, or plasma samples. Our Troponin T Rapid Test Device is an embodiment of efficiency, utilizing a qualitative, membrane-based immunoassay. The process is simple yet highly effective: the immunoassay begins by analyzing the sample provided, looking explicitly for cTnT. This component is a crucial biomarker present in blood when heart muscle damage is present, making it invaluable in diagnosing conditions such as myocardial infarction. Unlike traditional testing methods that can be time-consuming, our Troponin T Rapid Test Device is designed for speed without compromising accuracy. The whole process can be executed and completed within minutes. This makes it suitable for both clinical and emergency settings, assisting healthcare professionals to make prompt and informed decisions in critical situations. The Troponin T Rapid Test Device from QL Biotech, as part of the CMC Combo Test system, demonstrates our commitment to integrating sophisticated technology into healthcare. With this product, we aim to redefine the field of rapid medical diagnostics and strive to provide healthcare professionals with reliable, fast, and easy-to-use solutions. Remember, effective medical decisions are always based on accurate, timely knowledge. The Troponin T Rapid Test Device under our CMC Combo Test suite is at the forefront of providing this vital service. Harness the power of rapid testing, and ensure your healthcare facility is equipped for rapid response when it matters most.

The Troponin T Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative, membrane based immunoassay for the detection of cTnT in whole blood, serum or plasma. The membrane is pre-coated with Strepavidin-IgG on the test line region of the test and cTnT-biotin on the sample pad. During testing, the whole blood, serum or plasma specimen reacts with the cTnT-biotin on the sample pad frist, then migrates and react with the particle coated with anti-cTnT antibodies. The mixture migrates upward on the membrane chromatographically by capillary action to react with capture reagent on the membrane and generate a colored line. The presence of this colored line in the test line region indicates a positive result, while its absence indicates a negative result. To serve as a procedural control, a colored line will always appear in the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.

Sensitivity and Specificity

The Troponin T Rapid Test Device (Whole Blood/Serum/Plasma) has been evaluated with a leading commercial cTnT EIA test using clinical specimens. The results show that the sensitivity of the Troponin T Rapid Test Device (Whole Blood/Serum/Plasma) is 98.3% and the specificity is 98.4% relative to the leading EIA test.

Troponin T Rapid Test Device vs. EIA

 

Please note: Use as directed by a medical professional. Read all instructions thoroughly before use. Always use appropriate safety measures when handling blood, serum, or plasma samples. QL Biotech - advancing the field of rapid medical diagnostics one test at a time.